Search Results

You are looking at 1 - 2 of 2 items for :

  • Biochemistry x
Clear All
Open access

Spasoje Popević, Zorica Šumarac, Dragana Jovanović, Dragan Babić, Mihailo Stjepanović, Snežana Jovičić, Dragana Šobić-Šaranović, Snežana Filipović, Branko Gvozdenović, Maja Omčikus, Anđela Milovanović, Jelica Videnović-Ivanov, Ana Radović, Vladimir Žugić and Violeta Mihailović-Vučinić

Severity. Respiration 2008; 76: 234–8. 18. Brunner J, Scholl-Bürgi S, Zimmerhackl LB. Chitotriosidase as a marker of disease activity in sarcoidosis. Rheumatol Int 2007; 27: 1171–2. 19. Braun JJ, Kessler R, Constantinesco A, Imperiale A. 18F-FDG PET/CT in sarcoidosis management: review and report of 20 cases. Eur J Nucl Med Mol Imaging 2008; 35: 1537–43. 20. Mostard RLM, Voo S, van Kroonenburgh MJ, Verschakelen JA, Wijnen PA, Nelemans PJ, et al. Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis. Respir Med 2011

Open access

Zahra Heidari, Ali Moghtaderi, Hamidreza Mahmoudzadeh-Sagheb and Enam Alhagh Charkhat Gorgich

-X, Zee C-S. Magnetic resonance imaging- based volumetric analysis of basal ganglia nuclei and substantia nigra in patients with Parkinson’s disease. Neurosurgery. 2006;58(2):256-62. DOI: 10.1227/01.NEU.0000194845.19462.7B 17. Ghaemi M, Hilker R, Rudolf J, Sobesky J, Heiss W-D. Differentiating multiple system atrophy from Parkinson’s disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging. Journal of Neurology, Neurosurgery & Psychiatry. 2002;73(5):517-23. DOI: 10.1136/jnnp.73.5.517 18. Gocmen-Mas N